Nationwide Fund Advisors Purchases Shares of 15,073 Quotient Limited (QTNT)

Nationwide Fund Advisors purchased a new stake in Quotient Limited (NASDAQ:QTNT) during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 15,073 shares of the company’s stock, valued at approximately $111,000. Nationwide Fund Advisors owned 0.10% of Quotient Limited as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also modified their holdings of the company. Ameriprise Financial Inc. increased its holdings in shares of Quotient Limited by 5.2% during the second quarter. Ameriprise Financial Inc. now owns 1,829,895 shares of the company’s stock valued at $13,468,000 after acquiring an additional 90,057 shares in the last quarter. TIAA CREF Investment Management LLC bought a new stake in shares of Quotient Limited during the second quarter valued at approximately $520,000. Bank of New York Mellon Corp bought a new stake in shares of Quotient Limited during the second quarter valued at approximately $451,000. Teachers Advisors LLC bought a new stake in shares of Quotient Limited during the second quarter valued at approximately $345,000. Finally, Schwab Charles Investment Management Inc. bought a new stake in shares of Quotient Limited during the second quarter valued at approximately $341,000. 47.57% of the stock is currently owned by hedge funds and other institutional investors.

Shares of Quotient Limited (QTNT) opened at $4.22 on Tuesday. Quotient Limited has a 1-year low of $3.22 and a 1-year high of $7.74. The company has a debt-to-equity ratio of -5.17, a quick ratio of 0.86 and a current ratio of 1.36.

Several equities research analysts have recently commented on the company. Zacks Investment Research downgraded Quotient Limited from a “hold” rating to a “sell” rating in a report on Thursday, November 2nd. BTIG Research restated a “buy” rating and set a $12.00 price objective on shares of Quotient Limited in a report on Thursday, August 31st. Jefferies Group LLC decreased their price objective on Quotient Limited from $15.00 to $13.00 and set a “buy” rating for the company in a report on Wednesday, November 1st. Finally, ValuEngine downgraded Quotient Limited from a “sell” rating to a “strong sell” rating in a report on Friday, September 1st.

ILLEGAL ACTIVITY NOTICE: This story was first published by Sports Perspectives and is owned by of Sports Perspectives. If you are reading this story on another website, it was stolen and reposted in violation of US and international copyright and trademark legislation. The legal version of this story can be read at https://sportsperspectives.com/2017/11/21/nationwide-fund-advisors-purchases-shares-of-15073-quotient-limited-qtnt.html.

In related news, insider D J. Paul E. Cowan sold 30,197 shares of the company’s stock in a transaction on Monday, October 16th. The stock was sold at an average price of $4.92, for a total transaction of $148,569.24. Following the completion of the sale, the insider now owns 26,666 shares in the company, valued at $131,196.72. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, insider D J. Paul E. Cowan sold 100,000 shares of the company’s stock in a transaction on Wednesday, October 18th. The stock was sold at an average price of $4.64, for a total value of $464,000.00. Following the sale, the insider now owns 26,666 shares of the company’s stock, valued at approximately $123,730.24. The disclosure for this sale can be found here. Insiders have sold 275,197 shares of company stock valued at $1,258,319 in the last quarter. 29.00% of the stock is currently owned by corporate insiders.

About Quotient Limited

Quotient Limited is a diagnostics company. The Company focuses on blood grouping and donor disease screening, which is referred to as transfusion diagnostics. It is engaged in developing, manufacturing and commercializing conventional reagent products used for blood grouping within the global transfusion diagnostics market.

Want to see what other hedge funds are holding QTNT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Quotient Limited (NASDAQ:QTNT).

Institutional Ownership by Quarter for Quotient Limited (NASDAQ:QTNT)

Receive News & Ratings for Quotient Limited Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quotient Limited and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply